个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study

| 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Qu, Fengjiang[1] * ; Jiang, Tinghan[2] ; Liu, Zhenzhen[3,4] ; Ling, Rui[5] ; Zhao, Yi[6] ; Yang, Hongjian[7] ; Liu, Yunjiang[8] ; Liu, Ke[9] ; Zhang, Jianguo[10] ; Mao, Dahua[11] ; He, Jianjun[12] ; Yu, Zhigang[13] ; Liu, Yinhua[14] ; Fu, Peifen[15] ; Wang, Jiandong[16] ; Jiang, Hongchuan[17] ; Zhao, Zuowei[18] ; Tian, Xingsong[19] ; Cao, Zhongwei[20] ; Wu, Kejin[21] ; Song, Ailin[22] ; Jin, Feng[23] ; Wu, Di[24] ; Fan, Zhimin[24] ;
机构： [1]First Hosp Jilin Univ, Dept Emergency Surg, Changchun 130021, Jilin, Peoples R China [2]First Hosp Jilin Univ, Minist Educ, Changchun 130021, Jilin, Peoples R China [3]Zhengzhou Univ, Henan Breast Canc Ctr, Affiliated Canc Hosp, Dept Breast Dis, Zhengzhou 450008, Henan, Peoples R China [4]Henan Canc Hosp, Zhengzhou 450008, Henan, Peoples R China [5]Fourth Mil Med Univ, Xijing Hosp, Dept Thyroid Breast & Vasc Surg, Xian, Shaanxi, Peoples R China [6]China Med Univ, Shengjing Hosp, Surg Oncol Dept, Shenyang, Liaoning, Peoples R China [7]Univ Chinese Acad Sci, Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med & Canc IBMC,Dept Breast Surg,Canc H, Hangzhou 310022, Zhejiang, Peoples R China [8]Hebei Med Univ, Hosp 4, Dept Surg, Shijiazhuang, Hebei, Peoples R China [9]Jilin Canc Hosp, Dept Breast Surg 4, Changchun, Jilin, Peoples R China [10]Harbin Med Univ, Affiliated Hosp 2, Dept Breast Surg, Harbin 150086, Heilongjiang, Peoples R China [11]Guizhou Med Univ, Affiliated Wudang Hosp, Dept Breast Surg, Guiyang, Guizhou, Peoples R China [12]Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Breast Surg, Xian 710061, Shaanxi, Peoples R China [13]Shandong Univ, Hosp 2, Cheeloo Coll Med, Dept Breast Surg, Jinan 250033, Shandong, Peoples R China [14]Peking Univ First Hosp, Breast Dis Ctr, Beijing, Peoples R China [15]Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Breast Surg, Hangzhou 310003, Zhejiang, Peoples R China [16]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Gen Surg, Beijing 100852, Peoples R China [17]Capital Med Univ, Beijing Chaoyang Hosp, Dept Breast Surg, Beijing 100020, Peoples R China [18]Dalian Med Univ, Affiliated Hosp 2, Dept Breast Surg, Dalian 116023, Liaoning, Peoples R China [19]Shandong Univ, Shandong Prov Hosp, Dept Breast & Thyroid Surg, Jinan, Peoples R China [20]Inner Mongolia Autonomous Reg Peoples Hosp, Dept Thyroid, Breast, Hernia Surg, Hohhot 010017, Inner Mongolia, Peoples R China [21]Fudan Univ, Obstet & Gynecol Hosp, Dept Breast Surg, Shanghai, Peoples R China [22]Lanzhou Univ, Dept Gen Surg, Hosp 2, Lanzhou 730000, Gansu, Peoples R China [23]China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Liaoning, Peoples R China [24]First Hosp Jilin Univ, Gen Surg Ctr, Dept Breast Surg, Changchun 130021, Jilin, Peoples R China
出处：
DOI： 10.1016/j.isci.2025.112889
ISSN：

摘要：
The real-world application of tracers for axillary sentinel lymph node biopsy (SLNB) for breast cancer (BC) after neoadjuvant chemotherapy (NAC) in China was unknown. We analyzed the use of individual tracers or combinations and number of SLNs in patients with BC who underwent SLNB with or without axillary lymph node dissection (ALND) after NAC in 20 hospitals in ten years. A total of 1251 BC patients underwent SLNB or SLNB + ALND after NAC, including 853 (68.2%, 853/1251) with a single tracer, predominantly Methylene blue (MB) (60.1%, 752/1251); and 398 (31.8%, 398/1251) with dual tracers, mainly MB combined with radioisotope (RI) (18.1%, 226/1251).The results showed that the predominance of the MB single-tracer method for SLNB after NAC limits the popularity of SLNB in patients with BC after NAC in China. MB combined with RI is the main dual-tracer method, and detects SLNs more effectively than MB alone.

基金：
Chinese Society of Breast Surgery (CSBrS) - project of Doctor of excellence program (DEP); First Hospital of Jilin University, China [JDYY-DEP-20 23019]
语种：
外文
WOS：
PubmedID：
中科院分区：
出版当年[2025]版：
大类 | 2 区 综合性期刊
小类 | 2 区 综合性期刊
最新[2025]版：
大类 | 2 区 综合性期刊
小类 | 2 区 综合性期刊
JCR分区：
出版当年[2024]版：
Q1 MULTIDISCIPLINARY SCIENCES
最新[2024]版：
Q1 MULTIDISCIPLINARY SCIENCES

影响因子： 最新[2024版] 最新五年平均 出版当年[2025版] 出版当年五年平均 出版前一年[2024版]

第一作者：
第一作者机构： [1]First Hosp Jilin Univ, Dept Emergency Surg, Changchun 130021, Jilin, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Qu Fengjiang,Jiang Tinghan,Liu Zhenzhen,et al.Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study[J].ISCIENCE.2025,28(7):doi:10.1016/j.isci.2025.112889.
APA：
Qu, Fengjiang,Jiang, Tinghan,Liu, Zhenzhen,Ling, Rui,Zhao, Yi...&Fan, Zhimin.(2025).Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study.ISCIENCE,28,(7)
MLA：
Qu, Fengjiang,et al."Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study".ISCIENCE 28..7(2025)

资源点击量：42313 今日访问量：0 总访问量：1365 更新日期：2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持：重庆聚合科技有限公司 地址：河北省石家庄市健康路12号